{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T19:56:17Z","timestamp":1720209377892},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:00:00Z","timestamp":1375228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00059-013-3885-0","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T08:20:44Z","timestamp":1375086044000},"page":"610-617","source":"Crossref","is-referenced-by-count":4,"title":["Adipositas und kardiale Kachexie bei chronischer Herzinsuffizienz"],"prefix":"10.1007","volume":"38","author":[{"given":"M.","family":"Clauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Altenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,31]]},"reference":[{"key":"3885_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMoa0904130","volume":"362","author":"Franks","year":"2010","unstructured":"Franks PW, Hanson RL, Knowler WC et al (2010) Childhood obesity, other cardiovascular risk factors and premature death. N Engl J Med 362:485\u2013493","journal-title":"N Engl J Med"},{"key":"3885_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","volume":"347","author":"Kenchaiah","year":"2002","unstructured":"Kenchaiah S, Evans JC, Levy D et al (2002) Obesity and risk of heart failure. N Engl J Med 347:305\u2013313","journal-title":"N Engl J Med"},{"key":"3885_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","volume":"161","author":"He","year":"2001","unstructured":"He J, Ogden LG, Bazzano LA et al (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up-study. Arch Intern Med 161:996\u20131002","journal-title":"Arch Intern Med"},{"key":"3885_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCHEARTFAILURE.108.813782","volume":"2","author":"Loehr","year":"2009","unstructured":"Loehr LR, Rosamond WD, Poole C et al (2009) The association of multiple anthropometics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail 2(1):18\u201324","journal-title":"Circ Heart Fail"},{"key":"3885_CR5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","volume":"43","author":"Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC (2004) Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43:1439\u20131444","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurheartj\/ehi055","volume":"26","author":"Lavie","year":"2005","unstructured":"Lavie CJ, Mehra MR, Milani RV (2005) Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 26:5\u20137","journal-title":"Eur Heart J"},{"key":"3885_CR7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","volume":"38","author":"Horwich","year":"2001","unstructured":"Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38:789\u2013795","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-012-0059-5","volume":"3","author":"Lainscak","year":"2012","unstructured":"Lainscak M, Haehling S von, Doehner W, Anker SD (2012) The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 3:1\u20134","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/eurheartj\/ehi022","volume":"26","author":"Gustafsson","year":"2005","unstructured":"Gustafsson F, Kragelund CB, Torp-Pedersen C et al (2005) Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 26: 58\u201364","journal-title":"Eur Heart J"},{"key":"3885_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejheart.2007.12.010","volume":"Fail10","author":"McMurray","year":"2008","unstructured":"McMurray JJV, Carson PE, Komajda M et al (2008) Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVED trial. Eur J Heart Fail10:149\u2013156","journal-title":"Eur J Heart"},{"key":"3885_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2008.02.014","volume":"156","author":"Oreopoulos","year":"2008","unstructured":"Oreopoulos A, Padwal R, Kalantar-Zadeh K et al (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156(1):13\u201322","journal-title":"Am Heart J"},{"key":"3885_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4065\/mcp.2010.0103","volume":"85","author":"Oreopoulos","year":"2010","unstructured":"Oreopoulos A, Ezekowitz JA, McAlister FA et al (2010) Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 85(7):609\u2013617","journal-title":"Mayo Clin Proc"},{"key":"3885_CR13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4065\/mcp.2010.0336","volume":"85","author":"Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh K, Streja E, Kovedsy CP et al (2010) The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 85(11):991\u20131001","journal-title":"Mayo Clin Proc"},{"key":"3885_CR14","doi-asserted-by":"crossref","unstructured":"Younge JO, Damen NL, Domburg RT van, Pedersen SS (2012) Obesity, health status and 7-year mortality in percutaneus coronary intervention: in search of an explanation for the obesity paradox. Int J Cardiol [Epub ahead of print]","DOI":"10.1016\/j.ijcard.2012.03.105"},{"key":"3885_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2011.09.039","volume":"162","author":"Doehner","year":"2011","unstructured":"Doehner W, Erdmann E, Cairns R et al (2011) Inverse relation of body weight change in mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 162(1):20\u201326","journal-title":"Int J Cardiol"},{"key":"3885_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-5273(02)00230-9","volume":"85","author":"Doehner","year":"2002","unstructured":"Doehner W, Anker SD (2002) Cardiac cachexia in early literature: a review of research prior to Medline. Int J Cardiol 85:7\u201314","journal-title":"Int J Cardiol"},{"key":"3885_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/hrt.24.3.257","volume":"24","author":"Katz","year":"1962","unstructured":"Katz AM, Katz PB (1962) Diseases oft he heart in the work of Hippokrates. Br Heart J 24:257\u2013264","journal-title":"Br Heart J"},{"key":"3885_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","volume":"85","author":"Anker","year":"2002","unstructured":"Anker SD, Sharma R (2002) The syndrome of cardiac cachexia. Int J Cardiol 85:51\u201366","journal-title":"Int J Cardiol"},{"key":"3885_CR19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","volume":"96","author":"Anker","year":"1997","unstructured":"Anker SD, Chua TP, Ponokowski P et al (1997) Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526\u2013534","journal-title":"Circulation"},{"key":"3885_CR20","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","volume":"349","author":"Anker","year":"1997","unstructured":"Anker SD, Ponikowski P, Varney S et al (1997) Wasting as independant risk factor for mortality in chronic heart failure. Lancet 349:1050\u20131053","journal-title":"Lancet"},{"key":"3885_CR21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/07853890410017467","volume":"36","author":"Anker","year":"2004","unstructured":"Anker SD, Steinborn W, Strasburg S (2004) Cardiac cachexia. Ann Med 36:518\u2013529","journal-title":"Ann Med"},{"key":"3885_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","volume":"1","author":"Von","year":"2010","unstructured":"Von Haeling S, Anker SD (2010) Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 1:1\u20135","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J et al (2008) Cachexia: a new definition. Clin Nutr 27:793\u2013799","journal-title":"Clin Nutr"},{"key":"3885_CR24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","volume":"29","author":"Muscaritoli","year":"2010","unstructured":"Muscaritoli M, Anker SD, Argil\u00e9s J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ecachexia-anorexia in chronic wasting diseases\u201c and \u201enutrition in geriatrics\u201c. Clin Nutr 29:154\u2013159","journal-title":"Clin Nutr"},{"key":"3885_CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","volume":"90","author":"Anker","year":"2004","unstructured":"Anker SD, Haehling S von (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90:464\u2013470","journal-title":"Heart"},{"key":"3885_CR26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","volume":"20","author":"Anker","year":"1999","unstructured":"Anker SD, Ponikowski P, Clark AL et al (1999) Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20:683\u2013689","journal-title":"Eur Heart J"},{"key":"3885_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","volume":"85","author":"Anker","year":"2002","unstructured":"Anker SD, Sharma R (2002) The syndrome of cardiac cachexia. Int J Cardiol 85:51\u201366","journal-title":"Int J Cardiol"},{"key":"3885_CR28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","volume":"93","author":"Torre","year":"1996","unstructured":"Torre Amione G, Kapadia S, Lee J et al (1996) Tumor necrosis factor alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704\u2013711","journal-title":"Circulation"},{"key":"3885_CR29","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/ndt\/gfl281","volume":"21","author":"Kotanko","year":"2006","unstructured":"Kotanko P, Carter M, Levin NW (2006) Intestinal bacterial microflora \u2013 a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 21:2057\u20132060","journal-title":"Nephrol Dial Transplant"},{"key":"3885_CR30","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0002-9149(02)02839-4","volume":"90","author":"Genth-Zotz","year":"2002","unstructured":"Genth-Zotz S, Haeling S von, Bolger AP et al (2002) Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol 90:1226\u20131230","journal-title":"Am J Cardiol"},{"key":"3885_CR31","doi-asserted-by":"crossref","first-page":"954956","DOI":"10.1155\/2013\/954956","volume":"2013","author":"Kubotera","year":"2013","unstructured":"Kubotera N, Prokopienko AJ, Garba AO, Pai AB (2013) Endotoxin binding by Sevelamer: potential impact on nutritional status. Int J of Nephrol 2013:954956","journal-title":"Int J of Nephrol"},{"key":"3885_CR32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"Levine","year":"1990","unstructured":"Levine B, Kalmann J, Mayer L et al (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236\u2013241","journal-title":"N Engl J Med"},{"key":"3885_CR33","first-page":"446","volume":"4","author":"Hilt","year":"2005","unstructured":"Hilt W (2005) Das Ubiquitin-Proteasom-System in Proteinqualit\u00e4tskontrolle und Regulation. Biospektrum 4:446\u2013449","journal-title":"Biospektrum"},{"key":"3885_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.yjmcc.2011.10.023","volume":"52","author":"Portbury","year":"2012","unstructured":"Portbury Al, Ronnebaum SM, Zungu M et al (2012) Back to the heart: ubiquitin proteasome system- regulated signal transduction. J Mol Cell Cardiol 52(3):526\u2013537","journal-title":"J Mol Cell Cardiol"},{"key":"3885_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-011-0020-z","volume":"2","author":"Kung","year":"2011","unstructured":"Kung T, Szab\u00f3 T, Springer J et al (2011) Cachexia in heart disease: highlights from ESC 2010. J Cachexia Sarcopenia Muscle 2:63\u201369","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-010-0007-1","volume":"1","author":"Lenk","year":"2010","unstructured":"Lenk K, Schuler G, Adams V (2010) Skelatal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 1:9\u201321","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJM199612193352507","volume":"335","author":"Mitch","year":"1996","unstructured":"Mitch WE, Goldberg AL (1996) Mechanisms of muscle wasting. The role oft the ubiquitine-proteasome pathway. N Engl J Med 335:1897\u20131905","journal-title":"N Engl J Med"},{"key":"3885_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00000658-200101000-00003","volume":"233","author":"Hasselgren","year":"2001","unstructured":"Hasselgren PO, Fischer JE (2001) Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 233:9\u201317","journal-title":"Ann Surg"},{"key":"3885_CR39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13539-011-0045-3","volume":"2","author":"Slimani","year":"2011","unstructured":"Slimani L, Dubost A, Meunier B et al (2011) During early recovery the worsening of immobilization-induced rat tibialis anterior muscle atrophy is associated with sustained activation of proteolytic and apoptotic pathways. J Cachexia Sarcopenia Muscle 2:209\u2013261","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13539-011-0043-5","volume":"2","author":"Trobec","year":"2011","unstructured":"Trobec K, Haehling S von, Anker SD, Lainscak M (2011) Growth hormone, insulin-like growth factor 1 and insulin signalling \u2013 a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle 2:191\u2013200","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR41","first-page":"1324","volume":"25","author":"Higaki","year":"1997","unstructured":"Higaki K, Matsumoto Y, Fujimoto R et al (1997) Pharmacokinetics of recombinant human insulin-like growth factor-I in diabetic rats. Drug Metab Dispos 25:1324\u20131327","journal-title":"Drug Metab Dispos"},{"key":"3885_CR42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.85.2.799","volume":"85","author":"Ottosson","year":"2000","unstructured":"Ottosson M, L\u00f6nnroth P, Bj\u00f6rntorp P, Ed\u00e9n S (2000) Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 85:355\u2013360","journal-title":"J Clin Endocrinol Metab"},{"key":"3885_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/bj1840355","volume":"184","author":"Thomas","year":"1979","unstructured":"Thomas SH, Wisher MH, Brandenburg D, S\u00f6nksen PH (1979) Evidence that the anti-liplytic and lipogenic effects of insulin are mediated by the same receptor. Biochem J 184:355\u2013360","journal-title":"Biochem J"},{"key":"3885_CR44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.hjr.0000173106.68485.b7","volume":"12","author":"Hambrecht","year":"2005","unstructured":"Hambrecht R, Schulze PC, Gielen S et al (2005) Effects of exercise training on insulin-like growth factor-1 expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 12:401\u2013406","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"3885_CR45","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","volume":"96","author":"Anker","year":"1997","unstructured":"Anker SD, Chua TP, Ponikowski P et al (1997) Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance in cardiac cachexia. Circulation 96:526\u2013534","journal-title":"Circulation"},{"key":"3885_CR46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0735-1097(98)00226-5","volume":"32","author":"Niebauer","year":"1998","unstructured":"Niebauer J, Pflaum CD, Clark AL et al (1998) Deficient insulin-like growth factor 1 in chronic heart failure predicts altered body composition, anabolic defiency, cytokine and neurohumoral activation. J Am Coll Cardiol 32:393\u2013397","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","volume":"38","author":"Anker","year":"2001","unstructured":"Anker SD, Volterrani M, Pflaum CD et al (2001) Aquired growth hormone resistence in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38:443\u2013452","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR48","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","volume":"21","author":"Suskin","year":"2000","unstructured":"Suskin N, McKelvie RS, Burns RJ et al (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21:1368\u20131375","journal-title":"Eur Heart J"},{"key":"3885_CR49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","volume":"341","author":"Takala","year":"1999","unstructured":"Takala J, Ruokonen E, Webster NR et al (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785\u2013792","journal-title":"N Engl J Med"},{"key":"3885_CR50","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/en.142.4.1489","volume":"142","author":"Brink","year":"2001","unstructured":"Brink M, Price SR, Chrast J et al (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insuline-like growth factor I. Endocrinology 142:1489\u20131496","journal-title":"Endocrinology"},{"key":"3885_CR51","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0002-9149(02)02885-0","volume":"90","author":"Anwar","year":"2002","unstructured":"Anwar A, Gaspoz JM, Pampallona S et al (2002) Effect of congestive heart failure on the insulin-like growth factor-1 system. Am J Cardiol 90(12):1402\u20131405","journal-title":"Am J Cardiol"},{"key":"3885_CR52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-5273(02)00239-5","volume":"85","author":"Brink","year":"2002","unstructured":"Brink M, Anwar A, Delafontaine P (2002) Neurohumoral factors in the development of catabolic\/anabolic imbalance and cachexia. Int J of Cardiol 85:111\u2013121","journal-title":"Int J of Cardiol"},{"key":"3885_CR53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI22324","volume":"115","author":"Song","year":"2005","unstructured":"Song YH, Li Y, Du J et al (2005) Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115:451\u2013458","journal-title":"J Clin Invest"},{"key":"3885_CR54","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing peptide from stomach. Nature 402:656\u2013660","journal-title":"Nature"},{"key":"3885_CR55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1677\/JME-09-0023","volume":"43","author":"Wagner","year":"2009","unstructured":"Wagner C, Caplan SR, Tannenbaum GS (2009) Interactions of ghrelin signaling pathways with the gH neuroendocrine axis: a new and experimentally tested model. J Mol Endocrinol 43:105\u2013119","journal-title":"J Mol Endocrinol"},{"key":"3885_CR56","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"Tschop","year":"2000","unstructured":"Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908\u2013913","journal-title":"Nature"},{"key":"3885_CR57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"Nakazato","year":"2001","unstructured":"Nakazato M, Murakami N, Date Y et al (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194\u2013198","journal-title":"Nature"},{"key":"3885_CR58","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.HYP.0000035395.51441.10","volume":"40","author":"Matsumura","year":"2002","unstructured":"Matsumura K, Tsuchihashi T, Fujii K et al (2002) Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 40:694\u2013699","journal-title":"Hypertension"},{"key":"3885_CR59","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/hc4201.097836","volume":"104","author":"Nagaya","year":"2001","unstructured":"Nagaya N, Uematsu M, Kojima M et al (2001) Elevated circulating level of ghrelin in cachexia related chronic heart failure. Circulation 104:2034\u20132038","journal-title":"Circulation"},{"key":"3885_CR60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13539-010-0011-5","volume":"1","author":"Akamizu","year":"2010","unstructured":"Akamizu T, Kangawa K (2010) Ghrelin for cachexia. J Cachexia Sarcopenia Muscle 1:169\u2013176","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13539-010-0012-4","volume":"1","author":"M\u00fcller","year":"2010","unstructured":"M\u00fcller TD, Perez-Tilve D, Tong J et al (2010) Ghrelin and its potential in the treatment of eating\/wasting disorders and cachexia. J Cachexia Sarcopenia Muscle 1:159\u2013167","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR62","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/hc3601.095575","volume":"104","author":"Nagaya","year":"2001","unstructured":"Nagaya N, Uematsu M, Kojima M et al (2001) Chronic administration of ghrelin improves left ventricular dysfunction and attenuates developement of cardiac cachexia in rats with heart failure. Circulation 104:1430\u20131435","journal-title":"Circulation"},{"key":"3885_CR63","doi-asserted-by":"crossref","first-page":"e26865","DOI":"10.1371\/journal.pone.0026865","volume":"6","author":"Palus","year":"2011","unstructured":"Palus S, Schur R, Akashi YJ et al (2011) Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model. PLoS One 6(11):e26865","journal-title":"PLoS One"},{"key":"3885_CR64","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","volume":"269","author":"Halaas","year":"1995","unstructured":"Halaas JL, Gajiwala KS, Maffei M et al (1995) Weight-reducing effects of plasma protein encoded by the obese gene. Science 269:543\u2013546","journal-title":"Science"},{"key":"3885_CR65","doi-asserted-by":"crossref","first-page":"287457","DOI":"10.1155\/2012\/287457","volume":"2012","author":"Engineer","year":"2012","unstructured":"Engineer DR, Garcia JM (2012) Leptin in anorexia and cachexia syndrome. Int J Pept 2012:287457","journal-title":"Int J Pept"},{"key":"3885_CR66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1450727","volume":"145","author":"Doehner","year":"2001","unstructured":"Doehner W, Pflaum CD, Rauchhaus M et al (2001) Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol 145:727\u2013735","journal-title":"Eur J Endocrinol"},{"key":"3885_CR67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-5273(00)00397-1","volume":"76","author":"Filippatos","year":"2000","unstructured":"Filippatos GS, Tsilias K, Venetsanou K et al (2000) Leptin serum levels in cachectic heart failure patients. Int J Cardiol 76:117\u2013122","journal-title":"Int J Cardiol"},{"key":"3885_CR68","first-page":"676","volume":"2","author":"McGaffin","year":"2009","unstructured":"McGaffin KR, Moravec CS, McTiernan CF (2009) Leptin signaling in the failing and mechanially unloaded human heart. Circulation 2:676\u2013683","journal-title":"Circulation"},{"key":"3885_CR69","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nm1010-1100","volume":"16","author":"Friedman","year":"2010","unstructured":"Friedman JM (2010) A tale oft two hormones. Nat Med 16:1100\u20131106","journal-title":"Nat Med"},{"key":"3885_CR70","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3202-10.2010","volume":"30","author":"Koch","year":"2010","unstructured":"Koch C, Augustine RA, Steger J et al (2010) Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 30:16180\u201316187","journal-title":"J Neurosci"},{"key":"3885_CR71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nm0604-563","volume":"10","author":"Friedman","year":"2004","unstructured":"Friedman JM (2004) Modern science versus the stigma of obesity. Nat Med 10:563\u2013569","journal-title":"Nat Med"},{"key":"3885_CR72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/en.139.2.551","volume":"139","author":"Mueller","year":"1998","unstructured":"Mueller WM, Gregoire FM, Stanhope KL et al (1998) Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139:551\u2013558","journal-title":"Endocrinology"},{"key":"3885_CR73","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1074\/jbc.271.5.2365","volume":"271","author":"Leroy","year":"1996","unstructured":"Leroy P, Dessolin P, Villageois P et al (1996) Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem 271:2365\u20132368","journal-title":"J Biol Chem"},{"key":"3885_CR74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCHEARTFAILURE.109.885525","volume":"3","author":"Van","year":"2010","unstructured":"Van Berendoncks AM, Garnier A, Beckers P et al (2010) Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 3:185\u2013194","journal-title":"Circ Heart Fail"},{"key":"3885_CR75","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"Pajvani","year":"2004","unstructured":"Pajvani UB, Hawkins M, Combs TP et al (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidine-mediated improvement in Insulin sensitivity. J Biol Chem 279:12152\u201312162","journal-title":"J Biol Chem"},{"key":"3885_CR76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.atherosclerosis.2011.11.038","volume":"220","author":"Beatty","year":"2012","unstructured":"Beatty AL, Zhang MH, Ku IA, Na B (2012) Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. Atherosclerosis 220:587\u2013592","journal-title":"Atherosclerosis"},{"key":"3885_CR77","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787\u20131847","journal-title":"Eur Heart J"},{"key":"3885_CR78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/2040622313480382","volume":"4","author":"De","year":"2013","unstructured":"De Maeyer C, Beckers P, Vrints CJ, Conraads VM (2013) Exercise training in chronic heart failure. Ther Adv Chronic Dis 4(3):105\u2013117","journal-title":"Ther Adv Chronic Dis"},{"key":"3885_CR79","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2005.12.050","volume":"47","author":"Passino","year":"2006","unstructured":"Passino C, Severino S, Poletti R et al (2006) Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47:1835\u20131839","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR80","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1053\/euhj.2002.3239","volume":"23","author":"Conraads","year":"2002","unstructured":"Conraads V, Beckers P, Bosmanns J et al (2002) Combined endurance\/exercise training reduces plasma TNF alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 23:1854\u20131860","journal-title":"Eur Heart J"},{"key":"3885_CR81","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0735-1097(01)01321-3","volume":"38","author":"Ennezat","year":"2001","unstructured":"Ennezat P, Malendowicz S, Testa M et al (2001) Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes. J Am Coll Cardiol 38:194\u2013198","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR82","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1161\/01.CIR.98.24.2709","volume":"98","author":"Hambrecht","year":"1998","unstructured":"Hambrecht R, Fiehn E, Weigl C, Gielen S (1998) Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98:2709\u20132715","journal-title":"Circulation"},{"key":"3885_CR83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0735-1097(03)00847-7","volume":"42","author":"Mann","year":"2003","unstructured":"Mann D, Reid M (2003) Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue. J Am Coll Cardiol 42:869\u2013872","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR84","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2007.02.055","volume":"49","author":"Haykowsky","year":"2007","unstructured":"Haykowsky M, Liang Y, Pechter D et al (2007) A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 49:2329\u20132336","journal-title":"J Am Coll Cardiol"},{"key":"3885_CR85","doi-asserted-by":"crossref","first-page":"e35708","DOI":"10.1371\/journal.pone.0035708","volume":"7","author":"Miki","year":"2012","unstructured":"Miki K, Maekura R, Nagaya N et al (2012) Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double blind, placebo-controlled trial. PLoS One 7(5):e35708","journal-title":"PLoS One"},{"key":"3885_CR86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13539-012-0061-y","volume":"3","author":"Ebner","year":"2012","unstructured":"Ebner N, Werner CG, Doehner W et al (2012) Recent developements in the treatment of cachexia: highlights from the 6th Cachexia Conference. J Cachexia Sarcopenia Muscle 3:45\u201350","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","volume":"2","author":"Dalton","year":"2011","unstructured":"Dalton JT, Barnette KG, Bohl CE et al (2011) The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2:153\u2013161","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR88","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13539-011-0045-3","volume":"2","author":"Dodson","year":"2011","unstructured":"Dodson S, Hancock ML, Johnston MA et al (2011) GTx-024, a selective androgen receptor modulator (SARM), improves physical function in non small-cell lung cancer (NSCLC) patients with muscle wasting. J Cachexia Sarcopenia Muscle 2:209\u2013261 (Abstract 8-07)","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR89","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13539-011-0045-3","volume":"2","author":"Dodson","year":"2011","unstructured":"Dodson S, Hancock ML, Johnston MA, Steiner MS (2011) In a phase IIb trial GTx-024 overcomes the negative impact of >8% weight loss on overall survival in non-small cell lung cancer (NSCLC) objects. J Cachexia Sarcopenia Muscle 2:209\u2013261 (Abstract 8-08)","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13539-011-0046-2","volume":"2","author":"Coats","year":"2011","unstructured":"Coats AJS, Srinivasan V, Surendran J et al (2011) The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of anabolic\/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design. J Cachexia Sarcopenia Muscle 2:201\u2013207","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","volume":"2","author":"Elkina","year":"2011","unstructured":"Elkina Y, Haeling S von, Anker SD, Springer J (2011) The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle 2:143\u2013151","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"McPheron","year":"1997","unstructured":"McPheron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83\u201390","journal-title":"Nature"},{"key":"3885_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V","volume":"180","author":"Sharma","year":"1999","unstructured":"Sharma M, Kambadur R, Mathews KG et al (1999) Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180:1\u20139","journal-title":"J Cell Physiol"},{"key":"3885_CR94","doi-asserted-by":"crossref","first-page":"E918","DOI":"10.1152\/ajpendo.00798.2007","volume":"294","author":"Allen","year":"2008","unstructured":"Allen DL, Cleary AS, Speaker KJ et al (2008) Myostatin, activin receptor IIb and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294:E918\u2013E927","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3885_CR95","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","volume":"121","author":"Haehling","year":"2009","unstructured":"Haehling S von, Lainscak M, Springer J, Anker SD (2009) Cardiac cachexia: a systematic overview. Pharmacol Ther 121:227\u2013252","journal-title":"Pharmacol Ther"},{"key":"3885_CR96","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"Lee","year":"2001","unstructured":"Lee SJ, McPheron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98:9306\u20139311","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3885_CR97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(94)90113-9","volume":"96","author":"Lee","year":"1994","unstructured":"Lee AH, Mull RL, Keenan GF et al (1994) Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 96:35\u201341","journal-title":"Am J Med"},{"key":"3885_CR98","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21244","volume":"39","author":"Rodino-Klapac","year":"2009","unstructured":"Rodino-Klapac LR, Haidet AM, Kota J et al (2009) Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39:283\u2013296","journal-title":"Muscle Nerve"},{"key":"3885_CR99","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfq039","volume":"12","author":"George","year":"2010","unstructured":"George I, Bish LT, Kamalakkannan G et al (2010) Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail 12:444\u2013453","journal-title":"Eur J Heart Fail"},{"key":"3885_CR100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","volume":"121","author":"Heineke","year":"2010","unstructured":"Heineke J, Auger-Messier M, Xu J et al (2010) Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 121:419\u2013425","journal-title":"Circulation"},{"key":"3885_CR101","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","volume":"63","author":"Wagner","year":"2008","unstructured":"Wagner KR, Fleckenstein JL, Amato AA et al (2008) A phase I\/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63:561\u2013571","journal-title":"Ann Neurol"},{"key":"3885_CR102","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIR.0b013e3181d0ba8b","volume":"121","author":"Springer","year":"2010","unstructured":"Springer J, Adams V, Anker SD (2010) Myostatin: regulator of muscle wasting in heart failure and treatment target for cardiac cachexia. Circulation 121:354\u2013356","journal-title":"Circulation"},{"key":"3885_CR103","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J et al (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531\u2013543","journal-title":"Cell"},{"key":"3885_CR104","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13539-010-0013-3","volume":"1","author":"Von","year":"2010","unstructured":"Von Haeling, Lainscak M, Doehner W et al (2010) Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J Cachexia Sarcopenia Muscle 1:187\u2013194","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3885_CR105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","volume":"34","author":"F\u00fclster","year":"2013","unstructured":"F\u00fclster S, Tacke M, Sandek A et al (2013) Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 34:512\u2013519","journal-title":"Eur Heart J"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-3885-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-013-3885-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-3885-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T17:57:16Z","timestamp":1563559036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-013-3885-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,31]]},"references-count":105,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["3885"],"URL":"https:\/\/doi.org\/10.1007\/s00059-013-3885-0","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,31]]}}}